Doctors say millions of people take medications that resulted from years of research and the pending research cuts have many ...

A Risky Business: Why Do Some Parkinson's Disease Treatments Affect Decision Making? Sep. 24, 2024 — Parkinson's disease, a debilitating nervous system disorder, is treated with medications that ...

More than 20,000 people are living with Parkinson's disease in Minnesota. And now, a new program is showing some promise when ...

A new study reveals disappointing results on the potential of GLP-1 drugs like Ozempic to treat Parkinson's disease ... a type 2 diabetes treatment made by AstraZeneca and available under the ...

The Vyafuser pump maintains a continuous, steady flow of the drug throughout the day and can be refilled at home by patients or their carers. "People living with advanced Parkinson's disease ...

WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson's disease have taken an hit. A new study found that a drug in the same class ...

The activity of the detected microbes can be determined based on the amount of C-D bonds. Credit: Xiaowei Ge (Boston University) A new study reveals that entacapone, a drug used to treat Parkinson’s ...

And some researchers hoped that the drugs could also help with some of the most difficult diseases to treat — those of the brain, like Parkinson ... diabetes treatment made by AstraZeneca ...

Denmark’s Lundbeck is bringing a third potential drug for Parkinson’s disease to the clinic – a human antibody that the company hopes will tackle the underlying cause of the condition.

Inhibikase Therapeutics is pausing work on its experimental Parkinson’s disease drug risvodetinib and seeking “strategic options” for the med after it came up short in the efficacy stakes.

Facial expression matters. Research has shown that quality of life is better in persons with Parkinson's who have undergone therapy to improve facial control than those who have not. Healthcare ...